ReviewWorld journal of gastroenterology2020
Medical management of metabolic and cardiovascular complications after liver transplantation.
Review in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Immunosuppression and vascular remodeling after liver transplantation: Mechanisms, surrogate markers, and modifiable pathways.World journal of transplantation · 2026Review
- Blood pressure control after solid organ transplantation: opportunities for optimizing care.Transplant international : official journal of the European Society for Organ Transplantation · 2026Article
- Metabolic syndrome after liver transplantation: A silent threat to long-term success.World journal of gastrointestinal pharmacology and therapeutics · 2025Review
- The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study.Acta diabetologica · 2025Article
- Trends, Clinical Characteristics, and Outcomes of Percutaneous Coronary Intervention in Liver Transplant Recipients.Clinical transplantation · 2025Article
- Key challenges of post-liver transplant weight management.World journal of transplantation · 2024Review
- Dental Sedation and General Anesthesia Considerations for Patients Posthepatic Transplantation.Anesthesia progress · 2024Review
- Advancements in Interventional Radiology for Managing Hepatic Encephalopathy: A Comprehensive Review.Cureus · 2024Review
- Design and evaluation of an educational mobile program for liver transplant patients.BMC health services research · 2023Article
- NAFLD: A pretransplant and post-transplant conundrum.Clinical liver disease · 2023Article
- Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients.Canadian journal of gastroenterology & hepatology · 2023Article
- Association between hospital acquired disability and post-discharge mortality in patients after living donor liver transplantation.BMC surgery · 2022Article
- Application of machine learning in liver transplantation: a review.Hepatology international · 2022Review
- Current aspects of renal dysfunction after liver transplantation.World journal of hepatology · 2022Review
- Is Intestinal Dysbiosis-Associated With Immunosuppressive Therapy a Key Factor in the Pathophysiology of Post-Transplant Diabetes Mellitus?Frontiers in endocrinology · 2022Article
- Nerve regeneration in transplanted organs and tracer imaging studies: A review.Frontiers in bioengineering and biotechnology · 2022Review
- Cardiovascular Evaluation of Liver Transplant Patients by Using Coronary Calcium Scoring in ECG-Synchronized Computed Tomographic Scans.Journal of clinical medicine · 2021Article
- Factors affecting anxiety, depression, and self-care ability in patients who have undergone liver transplantation.World journal of gastroenterology · 2021Article
- COVID-19 in Liver Transplant Recipients: A Systematic Review.Journal of clinical medicine · 2021Review
- Post-Liver Transplant Metabolic Syndrome.Journal of clinical and experimental hepatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Liver transplantation represents the only curative option for patients with end-stage liver disease, fulminant hepatitis and advanced hepatocellular carcinoma. Even though major advances in transplantation in the last decades have achieved excellent survival rates in the early post-transplantation period, long-term survival is hampered by the lack of improvement in survival in the late post transplantation period (over 5 years after transplantation). The main etiologies for late mortality are malignancies and cardiovascular complications. The latter are increasingly prevalent in liver transplant recipients due to the development or worsening of metabolic syndrome and all its components (arterial hypertension, dyslipidemia, obesity, renal injury,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.